Dyadic International, Inc. (DYAI)
0.3401
-0.03
(-7.25%)
USD |
NASDAQ |
Nov 05, 16:00
Dyadic International Gross Profit Margin (Quarterly) : -2.39% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.39% |
| March 31, 2026 | 28.72% |
| December 31, 2025 | 31.99% |
| September 30, 2025 | 12.07% |
| June 30, 2025 | 36.52% |
| March 31, 2025 | 24.36% |
| December 31, 2024 | 56.84% |
| September 30, 2024 | 79.78% |
| June 30, 2024 | 21.74% |
| March 31, 2024 | 56.99% |
| December 31, 2023 | 49.00% |
| September 30, 2023 | 73.33% |
| June 30, 2023 | 5.28% |
| March 31, 2023 | 25.67% |
| December 31, 2022 | 5.27% |
| September 30, 2022 | 31.47% |
| June 30, 2022 | 37.56% |
| March 31, 2022 | 37.58% |
| December 31, 2021 | -5.84% |
| September 30, 2021 | 43.35% |
| June 30, 2021 | 11.48% |
| March 31, 2021 | 15.16% |
| December 31, 2020 | 26.11% |
| September 30, 2020 | 35.88% |
| June 30, 2020 | -19.07% |
| Date | Value |
|---|---|
| March 31, 2020 | 11.79% |
| December 31, 2019 | 1.94% |
| September 30, 2019 | 15.34% |
| June 30, 2019 | 17.55% |
| March 31, 2019 | 18.53% |
| December 31, 2018 | 26.04% |
| September 30, 2018 | 7.45% |
| June 30, 2018 | 19.96% |
| March 31, 2018 | 20.35% |
| December 31, 2017 | 11.91% |
| September 30, 2017 | 19.08% |
| June 30, 2017 | 3.66% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 15.01% |
| September 30, 2016 | |
| June 30, 2016 | 8.72% |
| March 31, 2016 | 1.96% |
| December 31, 2015 | -6.33% |
| September 30, 2015 | 83.61% |
| June 30, 2015 | 40.14% |
| March 31, 2015 | 39.50% |
| December 31, 2014 | 33.01% |
| September 30, 2014 | 40.96% |
| June 30, 2014 | 29.50% |
| March 31, 2014 | 33.71% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | 98.50% |
| Amgen, Inc. | 73.09% |
| Anika Therapeutics, Inc. | 65.15% |
| BioCryst Pharmaceuticals, Inc. | 98.99% |
| Imunon, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -7.40K% |
| Return on Assets | -86.41% |
| Return on Invested Capital | -147.7% |
| Profit Margin (Quarterly) | -221.0% |
| Operating Margin (Quarterly) | -212.8% |
| Return on Net Operating Assets | -701.6% |